These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Unlicensed pharmaceutical preparations for clinical patient care: Ensuring safety. de Wilde S; de Jong MGH; Le Brun PPH; Guchelaar HJ; Schimmel KJM Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):3-8. PubMed ID: 29047193 [TBL] [Abstract][Full Text] [Related]
4. Generally Regarded As Safe. Novack GD Ocul Surf; 2017 Jan; 15(1):152-155. PubMed ID: 27871773 [No Abstract] [Full Text] [Related]
5. Preface. Dodd S Curr Drug Saf; 2019; 14(1):2. PubMed ID: 30698108 [No Abstract] [Full Text] [Related]
6. How can we discover safer drugs? Hornberg JJ; Mow T Future Med Chem; 2014 Apr; 6(5):481-3. PubMed ID: 24649949 [No Abstract] [Full Text] [Related]
7. Minimum acceptable requirements for introduction and marketing of drugs. Lasagna L Drugs; 1974; 7(6):409-13. PubMed ID: 4422210 [No Abstract] [Full Text] [Related]
8. Present attitudes of governmental drug regulatory agencies. Noel PR Int J Clin Pharmacol; 1973 Apr; 7(2):168-77. PubMed ID: 4731283 [No Abstract] [Full Text] [Related]
9. [Drug quality as a cause of drug related problems]. Sotoca-Momblona JM; Sisó-Almirall A Med Clin (Barc); 2006 Apr; 126(15):599. PubMed ID: 16756929 [No Abstract] [Full Text] [Related]
10. The drug regulatory process in Finland. Pirjola J; Holttinen K J Clin Pharmacol; 1989 Apr; 29(4):293-9. PubMed ID: 2723117 [No Abstract] [Full Text] [Related]
11. The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy. Simmons HE Int J Health Serv; 1974; 4(1):95-107. PubMed ID: 4829901 [No Abstract] [Full Text] [Related]
12. Regulating the safety of pharmaceuticals: the FDA, preemption, and the public's health. Gostin LO JAMA; 2009 May; 301(19):2036-7. PubMed ID: 19454642 [No Abstract] [Full Text] [Related]
13. Show drugs work before selling them. Sipp D; McCabe C; Rasko JE Nature; 2017 Mar; 543(7644):174-175. PubMed ID: 28277530 [No Abstract] [Full Text] [Related]
14. Drugs in the E.E.C. Lancet; 1972 Apr; 1(7757):944-5. PubMed ID: 4112105 [No Abstract] [Full Text] [Related]
15. Regulatory Factors Influencing Usage of Retinal Pharmaceuticals: A Look Both Home and Abroad. Croft DE; Wykoff CC; Michels S; Chakravarthy U; Cruess AF Am J Ophthalmol; 2016 Sep; 169():xiv-xvi. PubMed ID: 27485923 [No Abstract] [Full Text] [Related]
16. [European legislation on biological similarity recommendations of the European Agency on Medications concerning drug quality]. Prugnaud JL Nephrol Ther; 2009 Feb; 5 Spec No1():3-5. PubMed ID: 19233075 [No Abstract] [Full Text] [Related]
17. Necessary, optional, and undesirable drug products. Halperin JA Drug Intell Clin Pharm; 1983; 17(7-8):574-5. PubMed ID: 6872861 [TBL] [Abstract][Full Text] [Related]
18. The HEALTH Act's FDA defense to punitive damages: a gift to drug makers or to the public? Levy E Fordham Law Rev; 2006 Mar; 74(4):2425-60. PubMed ID: 17115481 [No Abstract] [Full Text] [Related]
19. [Europe and the drugs]. Duprat P Rev Prat; 1975 Jun; 25(34):2704-6. PubMed ID: 1162277 [No Abstract] [Full Text] [Related]
20. A counterfeit drug treaty: great idea, wrong implementation. Bate R; Attaran A Lancet; 2010 Oct; 376(9751):1446-8. PubMed ID: 21036261 [No Abstract] [Full Text] [Related] [Next] [New Search]